Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Documentation of structured medication counselling and medication reviews

From: A tailored programme to implement recommendations for multimorbid patients with polypharmacy in primary care practices—process evaluation of a cluster randomized trial

  Yes
% (n)*
No
% (n)*
1. Did you conduct structured medication counselling with this patient? 96.7 (116) 3.3 (4)
1.1 If yes, did the patient require any information? 53.4 (62) 46.5 (54)
1.2 If yes, did you receive any useful information from the patient or his/her relatives? 43.1 (50) 56.9 (66)
2. Did you conduct a complete inventory of the medication actually taken by the patient (“brown bag review”)? 82.5 (99) 17.5 (21)
2.1 If yes, did the patient bring his medication packages to the practice for this purpose? 74.7 (74) 25.3 (25)
2.2 If yes, were there any irregularities? 20.2 (20) 29.8 (79)
2.3 If yes, did you receive useful information due to the “brown bag review”? 31.3 (31) 67.7 (67)
2.4 If yes, did the brown bag review result in useful instructions for the patient? 43.4 (43) 56.6 (56)
3. Did you give the patient an updated medication list at the end of the appointment? 84.2 (101) 15.8 (19)
4. Did you review the medication of the patient systematically? 89.2 (107) 10.8 (13)
4.1 If yes, did you use the checklist for medication reviews provided by the study? 59.8 (64) 40.2 (43)
4.2 Did you use any other instrument for the medication review? 17.8 (19) 82.2 (88)
4.3 Did the medication review result in a change of the medication? 21.5 (23) 78.5 (84
4.4 If yes, what changes did you make?
 Stopping a medication 34.8 (8)  
 Prescription of a new drug 30.4 (7)  
 Change of the dosis 47.8 (11)  
 Change of application 0.0  
 Other 13.0 (3)  
  1. *Percentages refer to 120 medication counselling sessions documented by 8 GPs